Gontivimab Antibody
Gontivimab (ALX-0171) is a trivalent nanobody designed to neutralize respiratory syncytial virus (RSV) by targeting its fusion (F) protein. It has demonstrated potent antiviral activity in both in vitro assays and in vivo animal models of RSV infection, supporting its use in respiratory disease research.
Product Specifications
Product Name Alternative
VR465, VR-465, ALX0171, ALX-0171
Target
RSV
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Concentration
6.37 mg/mL
Purity
94.40% (May vary between batches)
Molecular Weight
42.14 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
